↓ Skip to main content

Design of a randomized controlled trial to evaluate effectiveness of methotrexate versus prednisone as first-line treatment for pulmonary sarcoidosis: the PREDMETH study

Overview of attention for article published in BMC Pulmonary Medicine, October 2020
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
31 Dimensions

Readers on

mendeley
41 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Design of a randomized controlled trial to evaluate effectiveness of methotrexate versus prednisone as first-line treatment for pulmonary sarcoidosis: the PREDMETH study
Published in
BMC Pulmonary Medicine, October 2020
DOI 10.1186/s12890-020-01290-9
Pubmed ID
Authors

Vivienne Kahlmann, Montse Janssen Bonás, Catharina C. Moor, Coline H. M. van Moorsel, Mirjam Kool, Raisa Kraaijvanger, Jan C. Grutters, Mayka Overgaauw, Marcel Veltkamp, Marlies S. Wijsenbeek

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 41 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 7 17%
Researcher 7 17%
Other 4 10%
Professor > Associate Professor 4 10%
Student > Doctoral Student 1 2%
Other 4 10%
Unknown 14 34%
Readers by discipline Count As %
Medicine and Dentistry 13 32%
Immunology and Microbiology 4 10%
Nursing and Health Professions 3 7%
Biochemistry, Genetics and Molecular Biology 2 5%
Pharmacology, Toxicology and Pharmaceutical Science 1 2%
Other 2 5%
Unknown 16 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 October 2020.
All research outputs
#18,761,080
of 23,253,955 outputs
Outputs from BMC Pulmonary Medicine
#1,424
of 1,967 outputs
Outputs of similar age
#314,345
of 419,318 outputs
Outputs of similar age from BMC Pulmonary Medicine
#26
of 41 outputs
Altmetric has tracked 23,253,955 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,967 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.5. This one is in the 17th percentile – i.e., 17% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 419,318 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 41 others from the same source and published within six weeks on either side of this one. This one is in the 21st percentile – i.e., 21% of its contemporaries scored the same or lower than it.